MarketInOut Stock Screener Log In | Sign Up
 

Nexalin Technology Inc

NASDAQ • Healthcare • Medical Devices • Quote as of 10/16/2026 16:00
Nexalin Technology Inc stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization2.37 mln
Float0.65 mln
Earnings Date11/13/2026

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

-5.45
Highly reliable

1-Year Forecast

15.00
Transformational upside

Relative Strength

1 / 100
Severely lagging

Pre-Tax Margin

-4,139%
Severely loss-making

ROE

-238
Deeply negative

Business Description

Nexalin Technology is a Houston-based medical device company that develops non-drug neurostimulation treatments for a range of mental health conditions, including anxiety, depression, insomnia, PTSD, addiction, and chronic pain. The company operates in both the United States and China, offering a growing lineup of wearable headset devices that use bioelectronic technology to stimulate the brain without the need for medication or traditional therapy.

Key Fundamentals

EPS-13.38
ROE-238
RPS0.34
ROIC-938
ROA-195
EBITDA, mln-8.94
EV / EBITDA-0.25
EV / EBIT-0.25
Revenue, mln0.22
EV / Revenue10.43

Quote Details

Last 2.35
Change -0.1 (-4.08%)
Open 2.44
Volume 22,214
Turnover 52,203
Average Volume 3,046,721

Financial Ratios

Pre-Tax Profit Margin-4,139
Leverage Ratio1.98
Current Ratio1.25
Price / Book2.07
Price / Tangible Book7.51
Price / Sales12.29

Financial Strength

Altman Z-Score-53.49
Piotroski F-Score 3 / 9
Beneish M-Score-5.45
1-Year Target Price15.00
Short Ratio0.76
Short % of Float1.62

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -35.26% 3 / 100   
1 Month -53.92% 2 / 100   
2 Months -80.3% 2 / 100   
6 Months -83.09% 3 / 100   
1 Year -94.6% 4 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us